Alanyl-glutamine enriched total parenteral nutrition improves local, systemic, and remote organ responses to intraperitoneal bacterial challenge

JPEN J Parenter Enteral Nutr. 2001 Nov-Dec;25(6):346-51. doi: 10.1177/0148607101025006346.

Abstract

Background: Standard total parenteral nutrition (STD-TPN) may diminish host defense against infection. Glutamine (Gln) is suggested to enhance host immunity. This study investigated the effects of antecedent alanyl-glutamine enriched TPN (Ala-Gln-TPN) on host responses to intraperitoneal bacterial challenge compared with STD-TPN.

Methods: Rats were divided into STD-TPN and Ala-Gln-TPN groups. They received isocaloric and isonitrogenous nutrition for 7 days and were challenged intraperitoneally with E. coli. Rats were killed before (0 hour) challenge and at 2 and 6 hours after challenge. Bacterial numbers in peritoneal lavage fluid (PLF), liver, spleen, and blood were determined. Tumor necrosis factor-alpha (TNF), interleukin (IL)-8, and interferon-gamma (IFN) in plasma and PLF were measured. Hepatic TNF, splenic TNF, and splenic IFN levels were determined.

Results: The numbers of E. coli in systemic blood at 2 hours after intraperitoneal bacterial challenge were significantly lower in the Ala-Gln-TPN than in STD-TPN group. E. coli numbers in blood significantly correlated with those in the liver. The Ala-Gln-TPN also resulted in significantly higher PLF and hepatic TNF levels, higher splenic IFN levels, and lower plasma IL-8 levels at 6 hours after challenge compared with the STD-TPN.

Conclusions: Antecedent Ala-Gln enriched TPN enhance local, systemic, and remote organ immune responses to intraperitoneal bacterial challenge. Ala-Gln-TPN may enhance host defense and be more beneficial than standard TPN in sepsis.

MeSH terms

  • Animals
  • Ascitic Fluid / cytology
  • Ascitic Fluid / immunology
  • Ascitic Fluid / microbiology
  • Bacteremia / immunology
  • Dipeptides / administration & dosage*
  • Escherichia coli / growth & development*
  • Escherichia coli / immunology
  • Escherichia coli Infections / immunology*
  • Escherichia coli Infections / therapy*
  • Injections, Intraperitoneal
  • Interferon-gamma / analysis
  • Interleukin-8 / analysis
  • Liver / immunology
  • Liver / microbiology
  • Lung / cytology
  • Lung / immunology
  • Male
  • Parenteral Nutrition, Total*
  • Peritoneal Lavage
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Spleen / immunology*
  • Spleen / microbiology
  • Tumor Necrosis Factor-alpha / analysis

Substances

  • Dipeptides
  • Interleukin-8
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • alanylglutamine